2,531
Views
6
CrossRef citations to date
0
Altmetric
Minireview

Imatinib a Tyrosine Kinase Inhibitor: a potential treatment for SARS- COV-2 induced pneumonia

ORCID Icon &
Pages 68-72 | Received 07 Apr 2020, Accepted 01 Jun 2020, Published online: 18 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nousheen Bibi, Ayesha Farid, Sana Gul, Johar Ali, Farhat Amin, Umesh Kalathiya & Ted Hupp. (2022) Drug repositioning against COVID-19: a first line treatment. Journal of Biomolecular Structure and Dynamics 40:23, pages 12812-12826.
Read now

Articles from other publishers (5)

Abbas Jafari, Zeinab Esmaeilzadeh, Mohhamad Rafi Khezri, Hojat Ghasemnejad‐Berenji, Sarvin Pashapour, Sonia Sadeghpour & Morteza Ghasemnejad‐Berenji. (2022) An overview of possible pivotal mechanisms of Genistein as a potential phytochemical against SARS‐CoV‐2 infection: A hypothesis. Journal of Food Biochemistry 46:10.
Crossref
Javier García-Cárceles, Elena Caballero, Carmen Gil & Ana Martínez. (2021) Kinase Inhibitors as Underexplored Antiviral Agents. Journal of Medicinal Chemistry 65:2, pages 935-954.
Crossref
Ankush Yadav, Shubhangi Singh, Vivek Srivastava, Namrata Bardhan, Saloni Gupta, Paratpar Sarkar & Harsimrut Kaur. (2021) A Review Article on Vaccine Development and Therapeutics Approach Against SARS-CoV-2. The Open COVID Journal 1:1, pages 117-138.
Crossref
Oana-Stefana Purcaru, Stefan-Alexandru Artene, Edmond Barcan, Cristian Adrian Silosi, Ilona Stanciu, Suzana Danoiu, Stefania Tudorache, Ligia Gabriela Tataranu & Anica Dricu. (2021) The Interference between SARS-CoV-2 and Tyrosine Kinase Receptor Signaling in Cancer. International Journal of Molecular Sciences 22:9, pages 4830.
Crossref
Nanasaheb Thorat, Sabrina Pricl, Abdul K. Parchur, Sandeep B. Somvanshi, Qifei Li, Sachin Umrao & Helen Townley. (2021) Safeguarding COVID-19 and cancer management: drug design and therapeutic approach. Open Research Europe 1, pages 77.
Crossref